@Siva108, love your optimism mate. If FDA submission for paediatric use is filed at the end of Q3, approval will not be granted until the end of Jan 2017. Approvals for adult use to come after that. It's not a big problem, but I expect RAP share price to be in a holding pattern for the next month or so rather than kicking higher. Again, that's not a problem if you are patient.
Ann: Update on US Clinical Study-RAP.AX, page-27
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 210 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)